Diffusion-weighted and multiphase contrast-enhanced MRI as surrogate markers of response to neoadjuvant sunitinib in metastatic renal cell carcinoma
View/ Open
Published version
Embargoed until: 5555-01-01
Reason: Version not permitted
Embargoed until: 5555-01-01
Reason: Version not permitted
Volume
110
Pagination
616 - 624
DOI
10.1038/bjc.2013.790
Journal
British Journal of Cancer
Issue
ISSN
0007-0920